CA Patent

CA2135203A1 — Metering Spray Designed for Pernasal Application

Assigned to M&P Patent AG · Expires 1993-12-09 · 32y expired

What this patent protects

Described is a metering spray designed for pernasal application, the spray containing at least one sex hormone or at least one metabolic precursor of a sex hormone or at least one derivative of a sex hormone or combinations of these, excepting the precursors of testosterone, …

USPTO Abstract

Described is a metering spray designed for pernasal application, the spray containing at least one sex hormone or at least one metabolic precursor of a sex hormone or at least one derivative of a sex hormone or combinations of these, excepting the precursors of testosterone, or at least one biogenic amine, with the exception of catecholamines.

Drugs covered by this patent

Patent Metadata

Patent number
CA2135203A1
Jurisdiction
CA
Classification
—
Expires
1993-12-09
Drug substance claim
No
Drug product claim
No
Assignee
M&P Patent AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.